Regeneron Pharmaceuticals (NasdaqGS:REGN) is presenting new hematology pipeline data at the American Society of Hematology Annual Meeting in 2026. The data set spans first in class bispecific antibody...
Source LinkRegeneron Pharmaceuticals (NasdaqGS:REGN) is presenting new hematology pipeline data at the American Society of Hematology Annual Meeting in 2026. The data set spans first in class bispecific antibody...
Source Link
Comments